Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Medication Trials

Iowa

CNS medication trials in Iowa

12 CNS medication studies are recruiting participants at sites in 5 cities across Iowa as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 927-5768
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Iowa city with a recruiting study

By research area: Migraine (6), Depression (2), ADHD (1), Bipolar Disorder (1), Multiple Sclerosis (1), Parkinson's Disease (1).

Iowa City (4), West Des Moines (4), Ames (2), Sioux City (2), Waterloo (2).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Depression: recently updated in Iowa

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Recruiting in
    Iowa City
    Registry record
    NCT07196501 · updated
  2. Ketamine Alcohol (in Treatment-Resistant Depression)

    • Phase 2
    • Ages 18 to 55
    • All sexes
    Sponsor
    Mark Niciu
    Recruiting in
    Iowa City
    Registry record
    NCT02122562 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Iowa on ClinicalTrials.gov.

Bipolar disorder: recently updated in Iowa

  1. A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)

    • Phase 2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Waterloo
    Registry record
    NCT07286175 · updated

Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Iowa on ClinicalTrials.gov.

ADHD: recently updated in Iowa

  1. Stimulant Effects on Disruptive Behavior

    • Phase 4
    • From 48 months, up to 12 years
    • All sexes
    Sponsor
    Matthew J O'Brien, PhD, BCBA-D
    Recruiting in
    Iowa City
    Registry record
    NCT03420339 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Iowa on ClinicalTrials.gov.

Parkinson's disease: recently updated in Iowa

  1. Tenapanor in Synucleinopathy-Related Constipation

    • Phase 2
    • Ages 50 to 89
    • All sexes
    Sponsor
    Cedar Valley Digestive Health Center
    Recruiting in
    Waterloo
    Registry record
    NCT06460038 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Iowa on ClinicalTrials.gov.

Multiple sclerosis (MS): recently updated in Iowa

  1. Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    TG Therapeutics, Inc.
    Recruiting in
    Iowa City
    Registry record
    NCT05877963 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Iowa on ClinicalTrials.gov.

Migraine: recently updated in Iowa

  1. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    Ames · Sioux City
    Registry record
    NCT07816367 · updated
  2. A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    West Des Moines
    Registry record
    NCT07645924 · updated
  3. A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Recruiting in
    West Des Moines
    Registry record
    NCT07674654 · updated
  4. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Sioux City · West Des Moines
    Registry record
    NCT04649242 · updated
  5. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    West Des Moines
    Registry record
    NCT04743141 · updated
  6. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Ames
    Registry record
    NCT05125302 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Iowa on ClinicalTrials.gov.

Ask about studies in Iowa

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.

CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5768

or send a short form

How should we reach you?

Call